180 related articles for article (PubMed ID: 32231682)
1. Pioneering Informed Consent for Return of Research Results to Breast Cancer Patients Facing Barriers to Implementation of Genomic Medicine: The Kenyan BRCA1/2 Testing Experience Using Whole Exome Sequencing.
Torrorey-Sawe R; van der Merwe N; Mining SK; Kotze MJ
Front Genet; 2020; 11():170. PubMed ID: 32231682
[TBL] [Abstract][Full Text] [Related]
2. Pioneering
Mampunye L; van der Merwe NC; Grant KA; Peeters AV; Torrorey-Sawe R; French DJ; Moremi KE; Kidd M; van Eeden PC; Pienaar FM; Kotze MJ
Front Oncol; 2021; 11():619817. PubMed ID: 34660253
[TBL] [Abstract][Full Text] [Related]
3. Implementation of multigene panel testing for breast and ovarian cancer in South Africa: A step towards excellence in oncology for the public sector.
van der Merwe NC; Ntaita KS; Stofberg H; Combrink HM; Oosthuizen J; Kotze MJ
Front Oncol; 2022; 12():938561. PubMed ID: 36568162
[TBL] [Abstract][Full Text] [Related]
4. Stakeholders' opinions on the implementation of pediatric whole exome sequencing: implications for informed consent.
Levenseller BL; Soucier DJ; Miller VA; Harris D; Conway L; Bernhardt BA
J Genet Couns; 2014 Aug; 23(4):552-65. PubMed ID: 23846343
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of BRCA1, BRCA2, and PALB2 genomic alterations among 924 Taiwanese breast cancer assays with tumor-only targeted sequencing: extended data analysis from the VGH-TAYLOR study.
Cheng HF; Tsai YF; Liu CY; Hsu CY; Lien PJ; Lin YS; Chao TC; Lai JI; Feng CJ; Chen YJ; Chen BF; Chiu JH; Tseng LM; Huang CC
Breast Cancer Res; 2023 Dec; 25(1):152. PubMed ID: 38098088
[TBL] [Abstract][Full Text] [Related]
6. Case Review: Whole-Exome Sequencing Analyses Identify Carriers of a Known Likely Pathogenic Intronic
Alenezi WM; Fierheller CT; Revil T; Serruya C; Mes-Masson AM; Foulkes WD; Provencher D; El Haffaf Z; Ragoussis J; Tonin PN
Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456503
[TBL] [Abstract][Full Text] [Related]
7. Exome Sequencing-Based Screening for BRCA1/2 Expected Pathogenic Variants Among Adult Biobank Participants.
Manickam K; Buchanan AH; Schwartz MLB; Hallquist MLG; Williams JL; Rahm AK; Rocha H; Savatt JM; Evans AE; Butry LM; Lazzeri AL; Lindbuchler DM; Flansburg CN; Leeming R; Vogel VG; Lebo MS; Mason-Suares HM; Hoskinson DC; Abul-Husn NS; Dewey FE; Overton JD; Reid JG; Baras A; Willard HF; McCormick CZ; Krishnamurthy SB; Hartzel DN; Kost KA; Lavage DR; Sturm AC; Frisbie LR; Person TN; Metpally RP; Giovanni MA; Lowry LE; Leader JB; Ritchie MD; Carey DJ; Justice AE; Kirchner HL; Faucett WA; Williams MS; Ledbetter DH; Murray MF
JAMA Netw Open; 2018 Sep; 1(5):e182140. PubMed ID: 30646163
[TBL] [Abstract][Full Text] [Related]
8. Globally Rare
Oosthuizen J; Kotze MJ; Van Der Merwe N; Myburgh EJ; Bester P; van der Merwe NC
Front Oncol; 2020; 10():619469. PubMed ID: 33643918
[TBL] [Abstract][Full Text] [Related]
9.
Huszno J; Pigłowski W; Mazur M; Pamuła-Piłat J; Zajkowicz A; Kierzkowska AF; Wojciechowska MO
Mol Clin Oncol; 2021 Nov; 15(5):222. PubMed ID: 34548921
[TBL] [Abstract][Full Text] [Related]
10. Family specific genetic predisposition to breast cancer: results from Tunisian whole exome sequenced breast cancer cases.
Hamdi Y; Boujemaa M; Ben Rekaya M; Ben Hamda C; Mighri N; El Benna H; Mejri N; Labidi S; Daoud N; Naouali C; Messaoud O; Chargui M; Ghedira K; Boubaker MS; Mrad R; Boussen H; Abdelhak S;
J Transl Med; 2018 Jun; 16(1):158. PubMed ID: 29879995
[TBL] [Abstract][Full Text] [Related]
11. BRCA1 and BRCA2 germline mutations in Chinese Hakka breast cancer patients.
Zhang Y; Wu H; Gan C; Rao H; Wang Q; Guo X
BMC Med Genomics; 2024 Jan; 17(1):3. PubMed ID: 38167124
[TBL] [Abstract][Full Text] [Related]
12. Next Generation Sequencing Reveals High Prevalence of BRCA1 and BRCA2 Variants of Unknown Significance in Early-Onset Breast Cancer in African American Women.
Ricks-Santi L; McDonald JT; Gold B; Dean M; Thompson N; Abbas M; Wilson B; Kanaan Y; Naab TJ; Dunston G
Ethn Dis; 2017; 27(2):169-178. PubMed ID: 28439188
[TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
14. A pilot study investigating feasibility of mainstreaming germline BRCA1 and BRCA2 testing in high-risk patients with breast and/or ovarian cancer in three tertiary Cancer Centres in Ireland.
McVeigh TP; Sweeney KJ; Brennan DJ; McVeigh UM; Ward S; Strydom A; Seal S; Astbury K; Donnellan P; Higgins J; Keane M; Kerin MJ; Malone C; McGough P; McLaughlin R; O'Leary M; Rushe M; Barry MK; MacGregor G; Sugrue M; Yousif A; Al-Azawi D; Berkeley E; Boyle TJ; Connolly EM; Nolan C; Richardson E; Giffney C; Doyle SB; Broderick S; Boyd W; McVey R; Walsh T; Farrell M; Gallagher DJ; Rahman N; George AJ
Fam Cancer; 2023 Apr; 22(2):135-149. PubMed ID: 36029389
[TBL] [Abstract][Full Text] [Related]
15. Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene.
Silvestri V; Zelli V; Valentini V; Rizzolo P; Navazio AS; Coppa A; Agata S; Oliani C; Barana D; Castrignanò T; Viel A; Russo A; Tibiletti MG; Zanna I; Masala G; Cortesi L; Manoukian S; Azzollini J; Peissel B; Bonanni B; Peterlongo P; Radice P; Palli D; Giannini G; Chillemi G; Montagna M; Ottini L
Cancer; 2017 Jan; 123(2):210-218. PubMed ID: 27648926
[TBL] [Abstract][Full Text] [Related]
16. The contribution of large genomic rearrangements in BRCA1 and BRCA2 to South African familial breast cancer.
van der Merwe NC; Oosthuizen J; Theron M; Chong G; Foulkes WD
BMC Cancer; 2020 May; 20(1):391. PubMed ID: 32375709
[TBL] [Abstract][Full Text] [Related]
17. Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank.
Abul-Husn NS; Soper ER; Odgis JA; Cullina S; Bobo D; Moscati A; Rodriguez JE; ; ; Loos RJF; Cho JH; Belbin GM; Suckiel SA; Kenny EE
Genome Med; 2019 Dec; 12(1):2. PubMed ID: 31892343
[TBL] [Abstract][Full Text] [Related]
18. Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer.
Kurian AW; Ward KC; Hamilton AS; Deapen DM; Abrahamse P; Bondarenko I; Li Y; Hawley ST; Morrow M; Jagsi R; Katz SJ
JAMA Oncol; 2018 Aug; 4(8):1066-1072. PubMed ID: 29801090
[TBL] [Abstract][Full Text] [Related]
19. BRCA1 and BRCA2 mutations and their clinical relevance in selected women diagnosed with triple-negative breast cancer in Kenya: a descriptive cross-sectional study.
Rioki JN; Muchiri L; Mweu M; Nyagol J; Songok E; Mwangi J; Oyaro M; Ong'ang'o LB; Rogena E
Pan Afr Med J; 2023; 45():102. PubMed ID: 37719058
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer in East Africa: Prevalence and spectrum of germline SNV/indel and CNVs in BRCA1 and BRCA2 genes among breast cancer patients in Tanzania.
Rweyemamu LP; Gültaşlar BK; Akan G; Dharsee N; Namkinga LA; Lyantagaye SL; Yazıcı H; Atalar F
Cancer Med; 2023 Feb; 12(3):3395-3409. PubMed ID: 35908255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
